Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luveris in ART for hyporesponders
NCT01071200Phase 3Terminated
- Sponsor
- Merck KGaA
- Start
- Mar 2005
- Primary completion
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lutropin alfa in infertility (2 arms), sponsored by Merck KGaA. Primary endpoint: Total Dose of Follicular Stimulating Hormone (FSH) for Retrieved Oocytes. Started Mar 2005; status: terminated.
02
Drugs
lutropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01071200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071200.